baber/WOPTO huggingface dataset:
Patent AU-594620-B2 (AU)
Title: Body fluid sample collection tube composite
Inventor: NUGENT EDWARD L
IPC: B01L3/00
Filed: 1988-06-16
Granted: 1990-03-08
Abstract: A composite body fluid sample container is provided which incorporates at least one dry chemistry test strip into the structure with a shrink-wrap film whereby a plurality of chemically impregnated patches are exposed simultaneously in a self-contained device to provide instant response to a specimen introduced into the container. Moreover, the device separates the test strip from the remainder of the specimen so as to provide for additional testing if required. In addition, the device maintains the specimen, and the impregnated test strip isolated from exposure to contamination while at the same time keeping the specimen, if diseased, from contaminating handlers of the device. Finally, the device protects against breakage and any resulting leakage or contamination.
Patent AU-687521-B2 (AU)
Title: Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
Inventor: KLEEMANN HEINZ-WERNER
IPC: C07C317/44
Filed: 1995-05-11
Granted: 1998-02-26
Abstract: Perfluoro alkyl-substd. benzoyl guanidine derivs. of formula (I) and their salts are new. R1 = SOmR6; m = 0-2; R6 = 1-6C perfluoroalkyl; R2, R3 = H, F, Cl, Br, I, 1-4C alkyl, 1-4C alkoxy, phenoxy (opt. mono-, di- or tri-substd. with F, Cl, Me or OMe); R4, R5 = H, 1-3C alkyl, F, Cl, Br, I, CN, OR7, NR8R9, (CH2)n-(CF2)p-CF3; R7- R9 = H or 1-4C alkyl; n = 0-1; p = 1-2.
Patent AU-685250-B2 (AU)
Title: Production of fibrinogen in transgenic animals
Inventor: GARNER IAN
IPC: A01K67/027
Filed: 1995-03-01
Granted: 1998-01-15
Abstract: Materials and methods for producing fibrinogen in transgenic non-human mammals are disclosed. DNA segments encoding Aα, Bβ and γ chains of fibrinogen are introduced into the germ line of a non-human mammal, and the mammal or its female progeny produces milk containing fibrinogen expressed from the introduced DNA segments. Non-human mammalian embryos and transgenic non-human mammals carrying DNA segments encoding heterologous fibrinogen polypeptide chains are also disclosed.
Patent AU-673143-B2 (AU)
Title: Hinged gel-filled security and environmental protection device
Inventor: RONEY KAREN
IPC: H02G15/113
Filed: 1992-06-08
Granted: 1996-10-31
Abstract: A hinge gel-filled environmental sealing and security protection device particularly designed for coaxial cables is described. More specifically, the invention utilizes at least one longitudinal pin and click-n-lock receptacle with a hinge opposite thereto.
Patent AU-566649-B2 (AU)
Title: Time base compression in pcm recording
Inventor: ODAKA KENTARO
IPC: G11B20/00
Filed: 1983-12-20
Granted: 1987-10-29
Abstract: Apparatus for recording an analog signal employs n rotary heads (1A, 1 B) (where n is a positive integer) which cooperate with a magnetic tape (2) wound around a tape guide drum (3) over an angular range of a° (where a° is less than or equal to 360°) and the rotary heads (1A, 1B) are rotated at a speed N (where N is greater than one) times a reference rotation speed. The input analog signal to be recorded is first converted to a pulse code modulated (PCM) data signal which is then time-base compressed by a ratio of (n x a°)/(N x 360°) at successive predetermined periods. The PCM data that has been compressed in time-base is recorded on the magnetic tape (2) by the n rotary heads (1A, 1B) during predetermined intervals that occur within the time when the n rotary heads (1A, 1B) are in contact with the magnetic tape (2). The time-base compression of the data permits the addition of error correction codes and parity words to provide error detection and correction during reproduction of the recorded digital signals and by raising the rotary head speed the number of memory units (16) required to perform the time-base compression is minimized.
Patent AU-682963-B2 (AU)
Title: Alpha-(pyrazol-3-yl)-oxymethylene-phenylbutenic acid methyl esters and the use thereof against harmful fungi or animal pests
Inventor: OBERDORF KLAUS
IPC: C07D403/04
Filed: 1995-04-25
Granted: 1997-10-23
Abstract: PCT No. PCT/EP95/01554 Sec. 371 Date Oct. 31, 1996 Sec. 102(e) Date Oct. 31, 1996 PCT Filed Apr. 25, 1995 PCT Pub. No. WO95/29896 PCT Pub. Date Nov. 9, 1995Methyl  alpha -phenylbutenoates of the formula I    <IMAGE>  I  where +E,uns --+EE  is a single or double bond and the index and the substituents have the following meanings: n is 0, 1, 2, 3 or 4; R1 is nitro, cyano, halogen, alkyl, haloalkyl or alkoxy; R2 is hydrogen, nitro, cyano, halogen, alkyl, haloalkyl, alkoxy, alkylthio or alkoxycarbonyl; R3 is unsubst. or subst. alkyl, alkenyl or alkynyl; an unsubst. or subst. saturated or mono-or diunsaturated ring which, in addition to carbon atoms, can contain one to three of the following heteroatoms as ring members: oxygen, sulfur and nitrogen, or an unsubst. or subst. mono- or binuclear aromatic radical which, in addition to carbon atoms, can contain one to four nitrogen atoms or one or two nitrogen atoms and an oxygen or sulfur atom or an oxygen or sulfur atom as ring members, processes for their preparation and their use are described.
Patent AU-711105-B2 (AU)
Title: Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter
Inventor: BUYL ERIC DE
IPC: A23L35/00
Filed: 1995-07-19
Granted: 1999-10-07
Abstract: A xylanase (X) from a Bacillus strain that is active at pH 5-10 and between temps. of 50-80 degrees C, is new. Also claimed are: (i) a culture of Bacillus sp 720/1; (ii) a DNA encoding (X); (iii) an expression vector or chromosomal integration vector containing the DNA of (ii); (iv) a strain transformed with the vector of (iii); (v) an enzyme composition contg. (X) and at least one additive; (vi) a promoter sequence derived from the gene encoding B. pumilus PRL B12 xylanase; and (vii) a presequence derived from the gene encoding B. pumilus PRL B12 xylanase.
Patent AU-678139-B2 (AU)
Title: Method of enantio selectively epoxidizing cinnamate derivatives
Inventor: JACOBSEN ERIC N
IPC: C07D493/10
Filed: 1992-08-26
Granted: 1997-05-22
Abstract: Chiral catalysts for enantioselectively epoxidizing a prochiral olefin and for enantioselectively oxidizing a prochiral sulfide are disclosed, together with methods of using such catalysts. In accordance with one aspect of the invention, the catalyst is a salen derivative which has general structure (I). In accordance with another aspect of the present invention is a method of producing an epoxychroman using a chiral catalyst. In accordance with this method, a chromene derivative, an oxygen atom source, and a chiral catalyst are reacted under such conditions and for such time as is needed to epoxidize said chromene derivative. In accordance with yet another aspect of this invention is a method of enantioselectively epoxidizing a cis-cinnamate derivative to make taxol or an analog thereof. In accordance with another aspect a method of disproportionation of hydrogen peroxide using the catalysts of the present invention is disclosed.
Patent AU-780689-B2 (AU)
Title: Process for the protection of reinforcement in reinforced concrete
Inventor: GLASS GARETH KEVIN
IPC: C23F13/02
Filed: 2001-01-26
Granted: 2005-04-14
Abstract: The invention provides a reinforced concrete having improved corrosion resistance in which the content of voids in the concrete at the surface of the steel reinforcement is below 0.8 %, preferably below 0.5 %, more preferably below 0.2 % by area of steel and in which there is a layer of solid alkali, preferably at least one micron in thickness on the steel surface. The reinforced concrete preferably has a chloride threshold level of at least 0.5 % preferably at least 0.8 % by weight of the cement. The invention also provides a process for reducing corrosion of steel reinforcement in concrete which comprises forming a reinforced concrete in which the voids at the steel surface are below 0.5 % by volume and in which there is a layer of solid alkali on the steel surface the layer being at least 1 micron in thickness and covering at least 20 % of the steel surface.
Patent AU-695230-B2 (AU)
Title: Compounds for and method of inhibiting phosphodiesterase IV
Inventor: CAVALLA DAVID
IPC: A61P11/06
Filed: 1995-06-23
Granted: 1998-08-06
Abstract: Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess similar or improved PDE IV inhibition as compared to rolipram, with improved selectivity with regard to, e.g., PDE III inhibition. Preferred compounds are 3-(3-cyclopentyloxy-4-methoxy-benzylamino)-4-hydroxymethyl pyrazole and 3-(3-cyclopentyloxy-4-methoxybenzylamino)-4-methoxymethylpyrazole.
Patent AU-620592-B2 (AU)
Title: System for low temperature refrigeration and chill storage using ammoniated complex compounds
Inventor: ROCKENFELLER UWE
IPC: F24V30/00
Filed: 1989-02-27
Granted: 1992-02-20
Abstract: An improved heat exchange system incorporates the cooling created by using a metal salt/ammonia ligand complex compound which is alternately heated and cooled to alternately desorb and adsorb, respectively, the ammonia creating useful cooling or refrigeration in the temperature range of between -65 DEG C to 15 DEG C.
Patent AU-661534-B2 (AU)
Title: Method for reducing volume of a radioactive composition
Inventor: NAGEL CHRISTOPHER J
IPC: C22B7/00
Filed: 1992-11-06
Granted: 1995-07-27
Abstract: A method is disclosed for producing a non-radioactive product from a radioactive waste composition that includes a radioactive component and a non-radioactive component. The method includes directing the radioactive waste into a molten metal bath. A separation agent is directed in the molten metal bath which reacts with a component of the radioactive waste composition to form a reaction product which separates from the remaining component, thereby forming a non-radioactive product. The separation reagent can be, for example, an oxidant, a metal-ligand exchange reagent, or a reducing agent. The non-radioactive product can be a gas, a liquid, or a precipitate.
Patent AU-717373-B2 (AU)
Title: Toilet cleansing block
Inventor: VELTMAN JEROME J
IPC: C11D1/68
Filed: 1997-05-14
Granted: 2000-03-23
Abstract: A toilet cleansing block contains anionic surfactant such as a sulfonate, linear primary alcohol such as Neodol TM  23, and binder such as hydroxy ethyl cellulose. The block erodes very slowly, yet at essentially identical rates in hard or soft water. The block is for use with a dispenser for immersion in toilet tanks or under the rim of a toilet basin.
Patent AU-713380-B2 (AU)
Title: Process for making phenyl heterocycles useful as cox-2 inhibitors
Inventor: ROSSEN KAI
IPC: C07C315/02
Filed: 1997-05-27
Granted: 1999-12-02
Abstract: The invention encompasses a process for making compounds of formula (I) or (Ia) useful in the treatment of cyclooxygenase-2 mediated diseases.
Patent AU-776482-B2 (AU)
Title: Method for the processing of a signal from an alarm and alarms with means for carrying out said method
Inventor: THUILLARD MARC PIERRE
IPC: G08B/
Filed: 2001-03-06
Granted: 2004-09-09
Abstract: The signals from an alarm, comprising at least one sensor (2, 3, 4), for monitoring characteristic hazard values and an analytical electronic unit (1), connected to the at least one sensor (2, 3, 4), are compared with pre-set parameters. Furthermore, the signals are analysed for repeated or regular occurrence and repeated, or regularly occurring alarm signals are classed as error signals. The classification of signals as error signals gives rise to a corresponding adjustment of the parameter. When an error signal arises, before the parameter is adjusted, the validity of the signal analysis for the at least one sensor (2, 3, 4) is checked and the parameter adjustment is carried out, depending upon the result of said validity check. An alarm with the means for carrying out said method comprises at least one sensor (2, 3, 4), for a characteristic hazard value and an electronic analysis unit (1), containing a microprocessor (6), for the evaluation and analysis of the signal from the at least one sensor (2, 3, 4). The microprocessor (6) has a software programme with an adaptive algorithm based on multiple solutions for the analysis of the signals from the at least one sensor (2, 3, 4).
Patent AU-668143-B2 (AU)
Title: Wheel chocking system for arresting road vehicles during transportation
Inventor: WINSOR ROBERT B
IPC: B60P3/077
Filed: 1993-02-26
Granted: 1996-04-26
Abstract: A wheel chocking system for restraining road vehicles being transported on a vehicle support surface of a transport vehicle is disclosed. The support surface has a grating disposed in at least a wheel support area where one or more road vehicles are positioned. The grating is formed by a grid of rods to which is secured chock members at desired positions relative to the position of the wheels of the road vehicle positioned over the wheel support area. Each chock has a base with disengageable attachment members in a lower engaging surface thereof to immovably secure the chock to the grating. The chock has an angled face plate which is positioned relative to an outer tread surface of a tire of a wheel to restrain movement thereof. Load transmitting members transfer a load applied to the face plate onto the base member and into the grating secured to the support surface. A lateral restraining member is provided on a side of the face plate and disposed adjacent an inner side wall portion of the tire to prevent lateral shifting of the vehicle positioned on the support surface.
Patent AU-741098-B2 (AU)
Title: Alkaloid glycoside for use as a medicament
Inventor: ATTARD GEORGE SIMON
IPC: A61K39/39
Filed: 1997-08-27
Granted: 2001-11-22
Abstract: The invention concerns an alkaloid glycoside for use in medicine. In a preferred aspect, the alkaloid glycoside is used for the stimulation of a class I-restricted immune response and/or a class II-restricted immune response. In a preferred aspect, the alkaloid glycoside is tomatine.
Patent AU-669205-B2 (AU)
Title: Teat
Inventor: MCINNES ROSS GORDON
IPC: A01K9/00
Filed: 1993-08-11
Granted: 1996-05-30
Abstract: PCT No. PCT/NZ93/00065 Sec. 371 Date Feb. 13, 1995 Sec. 102(e) Date Feb. 13, 1995 PCT Filed Aug. 11, 1993 PCT Pub. No. WO94/04023 PCT Pub. Date Mar. 3, 1994A teat for feeding liquids to animals adapted to be fastened to a source of liquid such as a pipe or drum in use to project outwardly from the source. The teat has a resilient outer end which is closed apart from a slit in it which slit is itself normally adapted to be closed by the resilience to provide a sufficient liquid seal. The closed outer end is preferably concave, coned, cusped or otherwise re-entrant. A reinforcing member such as webs are located, preferably internally on either side of the slit so that if the end of the teat is squashed or compressed by sucking forces exerted by the animal, with components along the direction of slit, the reinforcing member causes the slit to be pulled open, thereby allowing liquid to flow out of it in use. The pulling action allows an acceptable flow rate from a comparatively small slit which is less prone to leak than a large slit.
Patent AU-761060-B2 (AU)
Title: Method and apparatus for ultrasonic treatment of reflex sympathetic dystrophy
Inventor: TALISH ROGER J
IPC: A61H23/02
Filed: 2000-05-09
Granted: 2003-05-29
Abstract: The invention relates to apparatus and method for therapeutically treating reflex sympathetic dystrophy using ultra sound. The apparatus includes at least one ergonomically constructed ultrasonic transducer configured to cooperate with a placement module or strip for placement in proximity to pain receptors of the sympathetic nervous system. The apparatus also utilizes a portable, ergonomically constructed main operating unit constructed to fit within a pouch worn by the patient. In operation, at least one ultrasonic transducer positioned in proximity to the pain receptors of the sympathetic nervous system is excited for a predetermined period of time. To ensure that at least one ultrasonic transducer is properly positioned, and to insure compliance with a treatment protocol, a safety interlock is provided to prevent inadvertent excitation of the at least one ultrasonic transducer. In an alternate embodiment, the apparatus includes a treatment basin having a plurality of ultrasonic transducer assemblies placed on the perimeter thereof. The patient places an injured part of the body therein and the transducer assemblies are excited to impinge ultrasonic waves to the injured part of the body.
Patent AU-577248-B2 (AU)
Title: Connector for flat cable
Inventor: WOENSEL JOHANNES MARIA BLASIUS
IPC: H01R13/58
Filed: 1986-01-20
Granted: 1988-09-15
Abstract: A connector for contacting one or a plurality of parallel connectors and retaining the conductors at the contact position. The connector includes two parallel extending contacts between which the conductor is inserted and electrically contacted. The connector further includes rotable retaining means which enables the conductor to be inserted between the contacts and which also secures the conductor in place after it is contacted.
Patent AU-681604-B2 (AU)
Title: High speed programmable logic controller
Inventor: PALERMO ROBERT J
IPC: G06F9/38
Filed: 1993-08-25
Granted: 1997-09-04
Abstract: A high speed programmable logic controller is taught. Briefly stated a Programmable Logic Controller having memory, a microprocessor and a Co-Processor are operatively interconnected using a Harvard style architecture therefore having separate data and instruction busses. The Co-Processor acts as a Boolean Processor and is therefore able to simultaneously perform instruction fetches and executions thereby resulting in substantially increased overall speed of the PLC and therefore allowing for fast process control.
Patent AU-574572-B2 (AU)
Title: Process for the treatment of strongly acidic cation catalysts
Inventor: BRANDES GUNTER
IPC: B01J37/10
Filed: 1986-04-02
Granted: 1988-07-07
Abstract: A process for the treatment of a halogenated strongly acidic cation exchange resin catalyst on a styrene-divinylbenzene copolymerizate base which comprises treating the catalyst with deionized water at a temperature ranging from about 100 DEG  to about 150 DEG  C. in the absence of oxygen and metal ions is provided.
Patent AU-723332-B2 (AU)
Title: Method and system for quality management in therapeutic processes
Inventor: THIBAUT ERIC
IPC: G16H20/40
Filed: 1997-12-17
Granted: 2000-08-24
Abstract: The invention concerns a method for quality management in a therapeutic process, said process comprising steps of sampling cells from a patient, specific treatment of these cells according to a specific treatment protocol, and reinfusion into this patient of said treated cells. This method consists in: steps of identifying entities involved in the therapeutic process; steps of sequential and conditional validation of the therapeutic process; and steps of quality control. The steps of identification, validation, automatic computation (unit conversion, computation of the concentration values and of volumes) and control are carried out for each batch of samples taken from a given patient. The invention is applicable in treatment laboratories, in particular for cell therapy.
Patent AU-622801-B2 (AU)
Title: Bilateral anti-copying device for video systems
Inventor: HUSSEY JAMES W
IPC: G11B20/00
Filed: 1990-05-24
Granted: 1992-04-16
Abstract: A video system anti-copying device in which leading and trailing code sequences are inserted into the luminance portion of a video signal. These code sequences are visually manifested as dropouts on a video monitor. When the sequences match, operation of record circuitry in a video recorder is inhibited.
Patent AU-591688-B2 (AU)
Title: A growth-stimulating animal feed, a process for preparing it, and an additive to be used in it
Inventor: HARJU MATTI ERKKI
IPC: A23L27/30
Filed: 1986-07-17
Granted: 1989-12-14
Abstract: The invention provides a lactitol-containing feed which stimulates the growth of monogastric domestic animals, especially calves.
Patent AU-639476-B2 (AU)
Title: Cellular radio system
IPC: H04W72/08
Filed: 1990-07-31
Granted: 1993-07-29
Abstract: A cellular radio system has a plurality of base stations (BS) each for communicating with mobile stations (MS) in its vicinity, and each base station (BS) has means for determining that voice or data communication between the base station and the mobile station has temporarily ceased, and for initiating required signalling with the mobile station during that temporary cessation.
Patent AU-759291-B2 (AU)
Title: New crystal modification N of torasemide
Inventor: FILIC DARKO
IPC: A61P35/00
Filed: 1999-10-01
Granted: 2003-04-10
Abstract: New crystalline polymorph of torasemide, characterized by its powder x-ray diffraction pattern data; and its preparation by controlled acidification of alkaline torasemide solutions at specific temperatures and over specific periods. New crystal modification (form III) of torasemide, with spacings (d) between lattice planes, expressed in angstroms as 15.3898, 12.5973, 11.4565, 9.7973, 9.5493, 8.6802, 8.2371, 7.6351, 7.3356, 6.9759, 6.5351, 6.3240, 6.1985, 5.9521, 5.6237, 5.5623, 5.4040, 5.1119, 4.8738, 4.7865, 4.6986, 4.5985, 4.4602, 4.3405, 4.2552, 4.1829, 4.0768, 3.9377, 3.8659, 3.8429, 3.7801, 3.7248, 3.6239, 3.5556, 3.4825, 3.4130, 3.3055, 3.2298, 3.1786, 3.1278, 3.0699, 3.0078, 2.9549, 2.9056, 2.8541, 2.7686, 2.6988, 2.6610, 2.6293, 2.5549, 2.5236, 2.4485, 2.4161, 2.3671, 2.3133, 2.2788, 2.2312, 2.1852, 2.1468, 2.0957, 2.0617, 2.0273, 1.9896, 1.9688, 1.9274, 1.8853, 1.7931, 1.7449, 1.7169, 1.6512, 1.6122, 1.5601, 1.5320, 1.5057, 1.4521, and 1.3773. An independent claim is also included for the preparation of this new modification form III, by controlled acidification of an alkaline torasemide solution with inorganic or organic acids, with or without addition of a seed crystal, at a temperature of 0-35[deg]C within a period of 0.25-25 hours. ACTIVITY : Diuretic; cardiovascular; hypotensive; cardiant; ophthalmological; cytostatic; anticonvulsant; antiallergic; antiasthmatic. MECHANISM OF ACTION : None given.
Patent AU-771947-B2 (AU)
Title: Quinazoline derivatives as medicaments
Inventor: CHAKRAVARTY SARVAJIT
IPC: A61K39/395
Filed: 1999-08-27
Granted: 2004-04-08
Abstract: The invention is directed to methods to inhibit TGF-beta and/or p38-alpha kinase using compounds of the formula or the pharmaceutically acceptable salts thereof wherein R<SUP>3 </SUP>is a noninterfering substituent; each Z is CR<SUP>2 </SUP>or N, wherein no more than two Z positions in ring A are N, and wherein two adjacent Z positions in ring A cannot be N; each R<SUP>2 </SUP>is independently a noninterfering substituent; L is a linker; n is 0 or 1; and Ar' is the residue of a cyclic aliphatic, cyclic heteroaliphatic, aromatic or heteroaromatic moiety optionally substituted with 1-3 noninterfering substituents.